Osaic Holdings
FBLG icon

Osaic Holdings’s FibroBiologics FBLG Stock Holding History

Osaic Holdings’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203 Sell
154
-146
-49% -$868 ﹤0.01% 7556
2025
Q4 		$1.32K Sell
300
-100
-25% -$704 ﹤0.01% 7200
2025
Q3 		$4.82K Hold
400
– – ﹤0.01% 6764
2025
Q2 		$4.96K Buy
400
+125
+45% +$2.25K ﹤0.01% 6546
2025
Q1 		$4.95K Sell
275
-1,466
-84% -$41.9K ﹤0.01% 6184
2024
Q4 		$69.6K Sell
1,741
-904
-34% -$48.5K ﹤0.01% 4450
2024
Q3 		$163K Hold
2,645
– – ﹤0.01% 3824
2024
Q2 		$264K Buy
+2,645
New +$505K ﹤0.01% 3312

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Osaic Holdings's FBLG Position: Q1 2026 in Review

Osaic Holdings reduced its FibroBiologics (FBLG) stake by 49% in Q1 2026, selling an estimated $868 and leaving 154 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #7556.

Osaic Holdings first reported a position in FBLG in Q2 2024 and has held it in 8 quarters since. The position peaked at $264K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Osaic Holdings held 154 shares of FibroBiologics worth $203 as of Q1 2026.
  • Osaic Holdings sold 146 FibroBiologics shares in Q1 2026, an estimated $868.
  • FibroBiologics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7556 holding.
  • Osaic Holdings first reported a position in FibroBiologics in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's FibroBiologics position peaked at $264K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.